1Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998[J].Antimicrob Agents Chemother, 2000, 44(3):747-751.
2Sobel JD, Zervos M, Reed BD,et al. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications[J]. Antimicrob Agents Chemother, 2003,47(1): 34-38.
3Safdar A, Chaturvedi V, Koll BS, et al. Prospective, multicenter surveillance study of Candida glabrata: fluconaole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City[J]. Antimicrob Agents Chemother, 2002,46(10): 3268-3272.
4Holland J, Young ML, Lee O, et al. Vulvaginal carriage of yeasts other than Candida albicans[J]. Sex Transm Infect,2003,79(3):249-50.
5St-Germain G, Laverdiere M, Pelletier R, et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally surveillance study in Quebec,Canada[J]. J Clin Microbiol, 2001, 39(3):949-953.
